0001209191-19-021277.txt : 20190325
0001209191-19-021277.hdr.sgml : 20190325
20190325214655
ACCESSION NUMBER: 0001209191-19-021277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190321
FILED AS OF DATE: 20190325
DATE AS OF CHANGE: 20190325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patton Stephana Eilene
CENTRAL INDEX KEY: 0001698237
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 19703973
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
CITY: ALAMEDA
STATE: CA
ZIP: 94501
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-21
0
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001698237
Patton Stephana Eilene
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BLVD.
PALO ALTO
CA
94306
0
1
0
0
See Remarks
Stock Option ( Right to Buy)
14.31
2019-03-21
4
A
0
90000
0.00
A
2029-03-20
Common Shares
90000
90000
D
The option will vest as to 25% of the option shares on March 18, 2020 and vest as to the remaining shares in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date.
General Counsel, Corporate Secretary, and Chief Compliance Officer
/s/ Stephana Patton
2019-03-25